Litmys Managing Partner Harris Kaplan will attend LSX Congress USA 2026, taking place September 23–24, 2026, at the Hynes Convention Center in Boston.

Part of Biotech Week Boston, LSX Congress USA brings together biotech executives, pharmaceutical leaders, investors, and strategic partners to explore opportunities for financing, collaboration, and growth. The conference features executive-level discussions, company presentations, and one-on-one partnering meetings focused on advancing innovation across the life sciences industry.

For emerging and growing biotech companies, demonstrating clinical promise is only part of building a compelling investment and commercialization story. Understanding how physicians, payers, and patients will respond to a new therapy, and what may influence its adoption, can help inform critical development decisions well before launch.

Harris looks forward to connecting with industry leaders to discuss the importance of incorporating commercial considerations earlier in development, strengthening market potential assessments, and building strategies that translate scientific innovation into real-world adoption.

To connect with Harris, please reach out.